Abstract
Two years after acquiring Alabama-based Avanti Polar Lipids, Croda says it plans to build a second US lipid facility at a site it purchased in Lamar, Pennsylvania, a year ago. Croda, which also manufactures lipids in Leek, England, will receive $75 million in funding from the US Department of Defense and the Biomedical Advanced Research and Development Authority as part of the federal government’s effort to bolster domestic supply of critical drug and vaccine ingredients. The British firm says it will spend up to $58 million, bringing its total investment in the plant to $133 million. Demand for lipids has soared in recent years with the development of messenger RNA (mRNA) vaccines. Naked mRNA quickly degrades in the body. To get the genetic material to its target cells, vaccine developers combine it with a mixture of several sophisticated lipids to form lipid nanoparticles . Croda supplies Pfizer with lipids for
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
